|
Volumn 54, Issue 2, 2005, Pages 314-316
|
Differential modulation of p38 mitogen activated protein kinase and STAT3 signalling pathways by infliximab and etanercept in intestinal T cells from patients with Crohn's disease (multiple letter) [9]
|
Author keywords
[No Author keywords available]
|
Indexed keywords
4 (4 FLUOROPHENYL) 2 (4 METHYLSULFINYLPHENYL) 5 (4 PYRIDYL)IMIDAZOLE;
CASPASE;
CASPASE 3;
CD4 ANTIGEN;
ETANERCEPT;
INFLIXIMAB;
INTERLEUKIN 10;
JANUS KINASE;
MITOGEN ACTIVATED PROTEIN KINASE P38;
NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE;
SEMAPIMOD;
STAT3 PROTEIN;
STAT4 PROTEIN;
TUMOR NECROSIS FACTOR ALPHA;
APOPTOSIS;
AUTOCRINE EFFECT;
CROHN DISEASE;
DOWN REGULATION;
DRUG EFFICACY;
ENZYME ACTIVATION;
HUMAN;
IMMUNE RESPONSE;
IMMUNOCOMPETENT CELL;
IMMUNOMODULATION;
INTESTINE CELL;
LAMINA PROPRIA;
LETTER;
PRIORITY JOURNAL;
PROTEIN PHOSPHORYLATION;
SIGNAL TRANSDUCTION;
T LYMPHOCYTE;
T LYMPHOCYTE ACTIVATION;
T LYMPHOCYTE SUBPOPULATION;
ANTIBODIES, MONOCLONAL;
CROHN DISEASE;
HUMANS;
IMMUNITY, MUCOSAL;
IMMUNOGLOBULIN G;
INTESTINAL MUCOSA;
RECEPTORS, TUMOR NECROSIS FACTOR;
SIGNAL TRANSDUCTION;
T-LYMPHOCYTE SUBSETS;
|
EID: 19944432266
PISSN: 00175749
EISSN: None
Source Type: Journal
DOI: None Document Type: Letter |
Times cited : (14)
|
References (0)
|